All In MedTech

Device Trial Radar · NCT02305420

EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage

Last checked: Nov 19, 2026Latest source record: Feb 19, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Nov 2014

Primary completion

Jun 2017

Study completion Jun 14, 2017

Sponsor

Lead sponsor
FertilitySANot on our public-company list
Sponsor type
Industry
Collaborators
University of Adelaide
First posted
Dec 2, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 25 years, up to 41 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

EmbryoGen and BlastGen contain the cytokine growth factor Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), which has been documented to give significant benefit to this difficult group of patients. Results showed a highly significant effect of 44% relative improvement in ongoing implantation rate (p=0.001) in women who have previously miscarried (Ziebe et al 2013). We wish to undertake a randomised Controlled trial to determine if EmbryoGen/BlastGen media improves pregnancy outcomes in women with recurrent implantation failure, recurrent miscarriage and poor embryo development when compared to standard media.

Conditions

  • Recurrent Miscarriage
  • Infertility

Interventions

  • EmbryoGen/ BlastGen mediaDevice

    Embryos will be cultured in media containing Gm-CSF (EmbryoGen/ BlastGen media)

  • Standard Cook sequential mediaDevice

    Standard Cook IVF media will be used in the control arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Livebirth >20 weeksTime frame: 9 months after closure of trial (18 +9 months)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • FertilitySA

    Adelaide, South Australia, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.